| Literature DB >> 31507073 |
Cho-Won Kim1, Ryeo-Eun Go1, Eul Bee Ko1, Eui-Bae Jeung2, Min-Seok Kim3, Kyung-Chul Choi1.
Abstract
The heart is the first organ formed in the developing fetus, and abnormal development of the heart is a major cause of fetal death. The adverse effects of cigarette smoke on the heart have been well established, but it is not well understood how cigarette smoke components regulate signaling molecules and cardiac specific functions during the early differentiation stage of the embryonic heart. In this study, we identified changes in the size of mouse embryoid bodies (mEBs) in response to treatment with cigarette smoke extract (CSE) via regulation of HDAC2, p53, p21, and cyclin D1 protein expression, which are cardiac differentiation and cell-cycle markers, respectively. In addition, exposure of mouse embryonic stem cells (mESCs) to cigarette smoke components inhibited myocardial differentiation and development through the expression of HDAC1, HDAC2, GATA4, NKX2-5, TBX5, HAND1, and Troponin I. Long-term exposure studies showed that CSE and nicotine may delay the development of mouse cardiomyocytes from mESCs and inhibit the contractibility, which is a fundamental function of the heart. Taken together, these findings suggest that cigarette smoke components, including nicotine, may affect abnormal myocardial differentiation and development.Entities:
Keywords: HDACs; cardiomyocyte; cell cycle; cigarette smoke extract; mouse embryonic stem cells; myocardial differentiation; nicotine
Mesh:
Substances:
Year: 2019 PMID: 31507073 DOI: 10.1002/tox.22843
Source DB: PubMed Journal: Environ Toxicol ISSN: 1520-4081 Impact factor: 4.119